[Test. Optimize. Scale.] Podcast episode #101 featuring Amir Reichman

Written By Guest User

Meet Amir Reichman, BiondVax's CEO, on the 101st episode of the popular Test.Optimize.Scale podcast.

Amir's story ranges from being NeuroDerm's first employee, his move to the US and then to GSK Vaccines HQ in Belgium, the reason for his return to Israel, his early successes in pivoting BiondVax and his vision for transforming the company into a multi-asset pharmaceutical powerhouse, beginning with innovative and promising alpaca-derived nanosized antibody pipeline for COVID, psoriasis, and more.

Guest User
Previous

[Nasdaq] These Are Some of the Best Ideas from the Bio-Europe Spring Conference